GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
@MrIndia we know CTDA is aimed at circa 20 working days. IF the DHSC are meeting that target takes us to about next week, so I don't see why anyone should have been expecting it before then. As for commercial discussions, we'll hear when they're completed, which imo they will be. I don't buy either anyone saying they won't happen, nor anyone saying they know exactly when.
Yes, unfortunately that is effectively the current thinking with covid. Eventually epidemic not endemic. Whatever, we're pretty much always going to be testing for it one way or another (at least the type of testing this will be used for).
Had a look at that 'breathalyser'. It's neither an antigen nor a molecular test. It may be useful where neither is required or specified, however it is not in the same category as gdr's LAMP. That is all.
For anyone wanting to follow UK scientific discussion on Covid, this is a good one. There's a briefing every Fri (apparently you can submit questions if feeling nerdy)
https://www.independentsage.org/
Thanks furion, appreciated, just my thoughts. I guess where I'm going is I think it's attractive to some industries whatever (or despite what) governments decide. As the virus is dangerous to those industries and they'll have to continue to protect themselves (and more persuasively their expensive operations!). Guess we'll see, I hope soon enough!
I thought it looked so mid-week systemzero, hence taking a bit at 27.3 on wed. Now granted I might've been able to snipe a wee bit in the last few minutes on Fri at a smidge lower, but that's about it, you make your calls and the latter was a very short window! No prediction for Mon, but I do think it may be. We'll see where it's taken then. There will be rns's but anyone saying they know exactly when needs to post how!
Come on drlong (if you can), the rns also stated:
"As detailed in the announcement on 29 November, the product is being provided for review and evaluation to a range of potential commercial partners who have actively expressed interest in the product with regards to European opportunities."
https://www.lse.co.uk/rns/GDR/ce-ivd-certification-for-point-of-care-kit-cxuv3ae1xyfs4jz.html
Hi furion, my view ref "why would a business want to invest in a new method of testing" it will be where that method provides practical and financial advantages to them. Some businesses really DO need to know quickly and accurately whether people are positive, I'd cite care and anything maritime as examples, travel, and there are undoubtedly others such as sport. I'm not suggesting it will replace lft for more generic use, but rather where PCR level is clearly desired but currently awkward or untimely. Clinical use also. Jmo
Thanks deer, interesting, a couple of recent nature articles along a similar theme.
https://www.nature.com/articles/d41586-021-03619-8
https://www.nature.com/articles/d41586-021-00396-2
it's been a substantial development road on AIHL with the NHS trials last year (ref PALOH study), we saw the unit upgraded last autumn after feedback from those, and inclusion in NICE guidance (if that is what is coming in March) is for me the unlocker.